These 2 shares are focused on healthy long-term growth


I think the best way to invest is to focus on the long-term rather than the short-term.

If you can find shares that can keep growing for many years ahead you’re probably going to do well.

The healthcare sector has a few advantages compared to other sectors. The ageing demographics of Australia and other western nations means that demand may steadily rise across the board for a number of years. The healthcare sector is also somewhat supported by the government indirectly through various funding measures to patients, hospitals and so on.

With that in mind, these two ASX shares could be good ideas:

ResMed Inc (ASX: RMD)

ResMed is regarded as one of the highest-quality healthcare shares on the ASX. It has a global revenue base, is exposed to the growth area of sleep apnoea with its masks and continues to grow its profit margin.

A recent bonus to Resmed is that it is increasing its software as a service (SaaS) revenue, which is high-margin for the company. Its recent acquisitions in this space are very promising.

ResMed is trading at 34x FY20’s estimated earnings.

Paragon Care Ltd (ASX: PGC)

Paragon is a small cap healthcare distribution business which supplies clients like hospitals and aged care facilities with products like beds, devices and equipment.

Certain ‘legacy’ capital equipment businesses are being a drain on Paragon’s profit, which may substantially and negatively affect the FY19 result. However, if it can sell or improve that division then today’s share price could appear quite cheap on a longer-term outlook.

Paragon is also working on lowering costs and improving efficiencies. It believes it’s on track to achieve ‘continuing’ revenue of $240 million and continuing earnings before interest, tax, depreciation and amortisation (EBITDA) of $28 million in FY19.

It’s trading at 6x FY21’s estimated earnings, but there is no guarantee it will earn 6.6 cents in earnings per share (EPS) terms in two years from now.

Foolish takeaway

Both of these businesses could justify an investment. However, ResMed is trading at an all-time high whilst Paragon is going through troubles. Whilst it would be a bit of a gamble, I think Paragon can turn itself around, so I’d go for the value share choice.

These top ASX shares could also be great long-term options if they’re successful with their growth plans.

5 ASX Stocks For Long Term Investors

BRAND NEW! For a limited time, The Motley Fool Australia is giving away an urgent new investment report outlining our 5 favourite stocks for investors over 50.

-Each company boasts strong growth prospects over the next 3 to 5 years…

-Most importantly each pays a generous (and fully franked) dividend!

So if you’re looking to get your finances on track and you’re in or near retirement – we’ve got you covered!

You’re invited. Simply click the link below to discover all 5 shares we’re expressly recommending for INVESTORS 50 and OVER. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a brief time only.

CLICK HERE FOR YOUR FREE REPORT!

More reading

Motley Fool contributor Tristan Harrison owns shares of Paragon Care Limited. The Motley Fool Australia has recommended Paragon Care Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019



Source link Finance News Australia

Enter your Email Address

Leave a Reply

Your email address will not be published. Required fields are marked *